Yes, we are quite concerned about our ability to continue supporting. As you know, we are committed to advancing diabetes research, and we're working with a number of research partners to advance it. We're concerned about the research environment and the gains we've been making, given that there's a pullback in both private and public support.
Everybody is trying to work through this, but as you look at 2021 being the 100th anniversary of the discovery of insulin, this is the time we should be focused very much on continuing to support diabetes research through partnerships. We have a great partner with CIHR. We have great partners with some of the private corporations and private donors. However, this is being challenged right now given the negative economic impact of COVID-19.